
    
      This is a randomized, double-blind, sham-controlled study using electroencephalography (EEG)
      neurofeedback (NF) for 2-week treatment. Participants were randomly assigned 1:1 to NF group
      or sham-control group. The NF group performed six NF sessions every other day in about two
      weeks. The feedback value of the NF group was about SMR band, while in the control group was
      pseudo-random numbers. Apart from studying the effects of EEG-NF on severity of anxiety and
      cognitive function, the secondary outcomes are to examine biomarkers related to inflammatory
      activity. Scale assessments are performed before the initiation of treatment, week 1, week 2.
      The Digit Span test, Go/No-Go task Collection of blood, excrement and saliva takes place at
      two time points, at the baseline, week 2.
    
  